Preferred Label : alpha-Glucosidases;

MeSH definition : Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.;

MeSH synonym : maltase-glucoamylase; alpha glucosidase; maltases; maltase glucoamylase; alpha glucosidases; alpha-Glucosidase; Maltase;

MeSH hyponym : neutral alpha-Glucosidase; lysosomal alpha-Glucosidase; Lysosomal alpha Glucosidase; alpha-Glucosidase, Lysosomal; Acid Maltase; Neutral alpha Glucosidase; alpha-Glucosidase, Neutral; Neutral Maltase;

CISMeF hyponym : EC 3.2.1.-;

MeSH CAS label : alpha-D-Glucoside glucohydrolases;

MeSH Related Number : neutral alpha-Glucosidase; lysosomal alpha-Glucosidase; EC 3.2.1.20;

Registry Number MeSH : EC 3.2.1.20;

Related CAS MeSH : EC 3.2.1.- (Neutral alpha-Glucosidase); EC 3.2.1.20 (Lysosomal alpha-Glucosidase);

MeSH annotation : defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II;

Wikipedia link : https://en.wikipedia.org/wiki/Alpha-glucosidases;

Is substance : O;

UNII : EC 3.2.1.20;

Details


Main resources

You can consult :

Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.

https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nexviadyme
2022
false
false
false
Netherlands
French
drug approval
europe
avalglucosidase alfa
Avalglucosidase Alfa
Avalglucosidase Alfa
orphan drug production
glycogen storage disease type ii
drug evaluation
summary of product characteristics
syndication feed
package leaflet
enzyme replacement therapy
alpha-Glucosidases
infusions, intravenous
risk management
product surveillance, postmarketing
recombinant proteins
aged
pregnancy
drug evaluation, preclinical

---
https://ansm.sante.fr/tableau-atu-rtu/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2021
false
false
false
France
French
summary of product characteristics
package leaflet
Avalglucosidase Alfa
Avalglucosidase Alfa
adult
child
glycogen storage disease type ii
infusions, intravenous
alpha-Glucosidases
alpha-Glucosidases
dna, recombinant
GAA protein, human
GAA protein, human

---
https://www.has-sante.fr/jcms/p_3301137/fr/myozyme-50-mg-alglucosidase-alfa
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
enzyme replacement therapy
alglucosidase alfa
alpha-Glucosidases
glycogen storage disease type ii
adult
adolescent
child
Pompe's disease late onset
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2659919/fr/maladie-de-pompe
http://www.has-sante.fr/portail/jcms/c_2659918/fr/pnds-maladie-de-pompe
2016
false
false
false
France
French
practice guideline
glycogen storage disease type ii
general practice
glycogen storage disease type ii
glycogen storage disease type ii
infant
child
adolescent
signs and symptoms
glycogen storage disease type ii
adult
diagnosis, differential
truth disclosure
glycogen storage disease type ii
GAA protein, human
alpha-Glucosidases
GAA protein, human
alpha-Glucosidases
physical therapy modalities
pregnancy
watchful waiting
continuity of patient care
general practitioners

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2007/14464a-fra.php
Canada
French
alpha-Glucosidases
GAA protein, human
alpha-Glucosidases
pharmacovigilance note

---
https://www.inspq.qc.ca/sites/default/files/publications/1566_medsysthormonalcanicules.pdf
2012
false
Canada
French
corticosteroid therapy
Ezetimibe
extreme heat
risk factors
administration, oral
hypoglycemic agents
quebec
Drug-Related side effects and adverse reactions
hypolipidemic agents
population characteristics
Bibliographies as Topic
thyroid hormones
renal insufficiency
glyburide
iodine radioisotopes
mineralocorticoids
bromocriptine
insulin
dehydration
alpha-Glucosidases
alpha glucosidase inhibitors
guidelines for drug use
practice guideline
biguanides
biguanides
dipeptidyl peptidase 4 (DPP-4) inhibitors
dipeptidyl-peptidase iv inhibitors
glucagon-like peptide 1
water-electrolyte imbalance
niacin
nicotinic acid
bile acid sequestrants
fibrates
fibric acids
hmg coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
ezetimibe
anion exchange resins
reports and studies
thyroid hormones
diphosphonates
imidazoles
Zoledronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Myozyme
2012
United Kingdom
English
French
syndication feed
glycogen storage disease type ii
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases
treatment outcome
drug evaluation
orphan drug production
infusions, intravenous
child
adolescent
adult
aged
alpha-Glucosidases
alpha-Glucosidases
pregnancy
breast feeding
drug compounding
drug labeling
drug approval
GAA protein, human
alglucosidase alfa
alpha-Glucosidases
drug evaluation
package leaflet
summary of product characteristics

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00098
2011
false
false
false
Canada
GAA protein, human
drug information
powders
alpha-Glucosidases

---
http://www.cetl.net/a-la-une/article/recommandations-du-cetpompe
http://www.cetl.net/IMG/pdf/RECO_CETP_-_Modalites_d_utilisation_du_Myosyme001.pdf
2011
France
French
alpha-Glucosidases
GAA protein, human
glycogen storage disease type ii
continuity of patient care
practice guideline

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=103907
2011
France
scientific and technical information
alpha-Glucosidases
diarrhea
diarrhoea
glucan 1,4-alpha-glucosidase

---
http://www.has-sante.fr/portail/jcms/c_979774/myozyme-alpha-alglucosidase-enzyme-recombinante
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/myozyme_-_ct-7575.pdf
2010
France
French
GAA protein, human
alpha-Glucosidases
alglucosidase alfa
glycogen storage disease type ii
infusions, intravenous
treatment outcome
GAA protein, human
alpha-Glucosidases
orphan drug production
rare diseases
enzyme replacement therapy
alpha-Glucosidases
evaluation of the transparency committee
guidelines for drug use

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Myozyme_June-14-2007_f.pdf
2007
Canada
French
glycogen storage disease type ii
alpha-Glucosidases
GAA protein, human
alglucosidase alfa
alpha-Glucosidases
drug evaluation

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.